As of 2025-06-20, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is (1.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 64.66 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -102.0%.
The range of the Relative Valuation is (1.14) - (1.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 9.5x | 8.0x |
| Forward P/E multiples | 8.7x - 14.4x | 11.6x |
| Fair Price | (1.14) - (1.25) | (1.28) |
| Upside | -101.8% - -101.9% | -102.0% |
| Date | P/E |
| 2025-06-18 | -492.75 |
| 2025-06-17 | -482.76 |
| 2025-06-16 | -489.93 |
| 2025-06-13 | -476.74 |
| 2025-06-12 | -473.39 |
| 2025-06-11 | -478.42 |
| 2025-06-10 | -479.10 |
| 2025-06-09 | -481.47 |
| 2025-06-06 | -472.17 |
| 2025-06-05 | -456.32 |
| 2025-06-04 | -463.86 |
| 2025-06-03 | -469.88 |
| 2025-06-02 | -471.79 |
| 2025-05-30 | -447.48 |
| 2025-05-29 | -443.97 |
| 2025-05-28 | -440.54 |
| 2025-05-27 | -444.43 |
| 2025-05-23 | -440.39 |
| 2025-05-22 | -436.43 |
| 2025-05-21 | -450.22 |
| 2025-05-20 | -462.11 |
| 2025-05-19 | -458.45 |
| 2025-05-16 | -457.16 |
| 2025-05-15 | -453.65 |
| 2025-05-14 | -460.05 |
| 2025-05-13 | -472.47 |
| 2025-05-12 | -474.76 |
| 2025-05-09 | -505.24 |
| 2025-05-08 | -545.10 |
| 2025-05-07 | -539.69 |
| 2025-05-06 | -535.50 |
| 2025-05-05 | -552.95 |
| 2025-05-02 | -555.92 |
| 2025-05-01 | -538.70 |
| 2025-04-30 | -539.69 |
| 2025-04-29 | -539.23 |
| 2025-04-28 | -539.15 |
| 2025-04-25 | -532.07 |
| 2025-04-24 | -530.70 |
| 2025-04-23 | -521.02 |
| 2025-04-22 | -525.44 |
| 2025-04-21 | -518.20 |
| 2025-04-17 | -527.42 |
| 2025-04-16 | -527.34 |
| 2025-04-15 | -530.01 |
| 2025-04-14 | -523.68 |
| 2025-04-11 | -519.11 |
| 2025-04-10 | -496.25 |
| 2025-04-09 | -503.03 |
| 2025-04-08 | -480.48 |